Avidity Biosciences RNA 深 滬
已收盤 11-14 16:00:00 美东时间
70.80
-0.040
-0.06%
華盛通- 最 高71.09
- 今 開70.80
- 成交量 239.50万股
- 最 低 70.59
- 昨 收 70.84
- 總市值 85.67亿
- 52周最高 71.09
- 市盈率 靜 --
- 換手率 1.98%
- 52周最低 21.51
- 委 比 -47.66%
- 總股本 1.21亿
- 歷史最高 71.09
- 量 比 0.57
- 振 幅 0.71%
- 歷史最低 4.825
- 每 手 1
- 風險率 10.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Momentum movers: 10 stocks surging over 40% over the last month
Despite lingering uncertainty in the broader market following recent selloffs, investor enthusiasm has not been entirely dampened. In fact, several large-cap stocks have surged sharply, with some clim...
11-13 02:12
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
11-12 11:43
Chardan Capital Maintains Neutral on Avidity Biosciences, Maintains $72 Price Target
Chardan Capital analyst Keay Nakae maintains Avidity Biosciences (NASDAQ:RNA) with a Neutral and maintains $72 price target.
11-11 20:59
Avidity Biosciences Q3 EPS $(1.27) Misses $(1.11) Estimate, Sales $12.475M Beat $1.932M Estimate
Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(1.27) per share which missed the analyst consensus estimate of $(1.11) by 13.9 percent. This is a 95.38 percent decrease over losses of $(0.65) per share
11-11 05:24
Key deals this week: Qorvo, Chewy, Sotherly Hotels, Novartis, CSG Systems, and more
Here's a list of key deals reported across sectors this week: Skyworks Solutions (SWKS), which supplies radio frequency chips to Apple (AAPL) and other smartphone makers, has agreed to buy Qorvo (NASD...
11-02 03:15
美股周涨跌榜 | RNA周内大涨42.1%！获诺华120亿美元收购；阿根廷概念股全线飙升
RNA周内大涨42.1%，获诺华120亿美元收购；阿根廷概念股全线飙升，SUPV涨84.5%、END涨71.9%>>
11-01 10:35
美股10月涨跌榜 | 人工智能驱动存储需求激增！SanDisk9月飙升超77%，AMD9月大涨超58%
人工智能驱动存储需求激增！SanDisk9月飙升超77%，AMD9月大涨超58%；生物制药公司RNA月涨超60%，获诺华120亿美元收购>>
11-01 09:52
Weekly Recap: 13 Health Press Releases You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including new healthcare acquisitions, Halloween safety tips, and the adoption of AI in affordable heal...
10-31 18:22
美股大行评级 | 275美元！美银证券上调英伟达目标价；花旗上调思佳讯评级至"中性"，目标价从66美元升至91美元
今日重点评级关注：HC Wainwright & Co.：维持Unicycive Therapeutics"买入"评级，目标价从9美元升至22美元；花旗：维持Arcus Biosciences"买入"评级，目标价从54美元升至56美元
10-30 14:22
AI助听器、全球首发创新药……这些进博会好物提前剧透
为了推动医疗新质生产力发展，助力“健康中国2030”战略实施，第八届进博会医疗器械及医药保健展区以“健康中国，美好生活”为主题，汇聚全球顶尖医疗科技力量，呈现创...
10-30 11:57
